Cramer Rosenthal Mcglynn LLC Has $13.96 Million Stock Position in Xylem Inc. $XYL

Key Points

• Cramer Rosenthal Mcglynn LLC reduced its stake in Xylem Inc. by 39.1%, owning 116,843 shares valued at approximately $13.96 million after selling 74,967 shares.
• Xylem recently reported $1.26 earnings per share for the last quarter, surpassing analyst expectations of $1.15, with a revenue of $2.30 billion.
• The company announced a quarterly dividend of $0.40 per share, resulting in an annualized yield of 1.1%.

Cramer Rosenthal Mcglynn LLC cut its stake in Xylem Inc. (NYSE:XYL - Free Report) by 39.1% in the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 116,843 shares of the industrial products company's stock after selling 74,967 shares during the quarter. Cramer Rosenthal Mcglynn LLC's holdings in Xylem were worth $13,958,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of XYL. Valley National Advisers Inc. increased its stake in shares of Xylem by 84.9% in the 1st quarter. Valley National Advisers Inc. now owns 220 shares of the industrial products company's stock valued at $26,000 after acquiring an additional 101 shares during the last quarter. Perkins Coie Trust Co bought a new position in shares of Xylem during the 1st quarter valued at about $27,000. Center for Financial Planning Inc. lifted its holdings in shares of Xylem by 52.0% during the 1st quarter. Center for Financial Planning Inc. now owns 266 shares of the industrial products company's stock valued at $32,000 after purchasing an additional 91 shares in the last quarter. Heck Capital Advisors LLC bought a new position in Xylem in the fourth quarter valued at approximately $36,000. Finally, Headlands Technologies LLC boosted its holdings in shares of Xylem by 90.6% in the first quarter. Headlands Technologies LLC now owns 305 shares of the industrial products company's stock valued at $36,000 after buying an additional 145 shares during the period. 87.96% of the stock is owned by institutional investors.

Xylem Price Performance

NYSE:XYL traded down $0.63 during trading hours on Thursday, hitting $143.99. The company's stock had a trading volume of 961,010 shares, compared to its average volume of 1,237,550. The stock has a fifty day simple moving average of $135.71 and a 200-day simple moving average of $126.80. Xylem Inc. has a twelve month low of $100.47 and a twelve month high of $145.33. The company has a market capitalization of $35.05 billion, a P/E ratio of 37.40, a PEG ratio of 2.50 and a beta of 1.11. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.90 and a quick ratio of 1.43.

Xylem (NYSE:XYL - Get Free Report) last issued its quarterly earnings data on Thursday, July 31st. The industrial products company reported $1.26 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.15 by $0.11. The business had revenue of $2.30 billion during the quarter, compared to analyst estimates of $2.20 billion. Xylem had a net margin of 10.74% and a return on equity of 10.33%. The firm's quarterly revenue was up 6.1% on a year-over-year basis. During the same quarter last year, the business earned $1.09 EPS. Xylem has set its FY 2025 guidance at 4.700-4.850 EPS. On average, analysts anticipate that Xylem Inc. will post 4.65 EPS for the current fiscal year.

Xylem Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, September 25th. Stockholders of record on Thursday, August 28th will be given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 1.1%. The ex-dividend date is Thursday, August 28th. Xylem's dividend payout ratio (DPR) is 41.56%.

Analyst Ratings Changes

A number of brokerages have recently commented on XYL. Raymond James Financial upgraded Xylem to a "hold" rating in a report on Thursday, May 15th. UBS Group boosted their price objective on shares of Xylem from $164.00 to $168.00 and gave the stock a "buy" rating in a research report on Tuesday, August 5th. Royal Bank Of Canada boosted their price objective on shares of Xylem from $143.00 to $147.00 and gave the stock an "outperform" rating in a research report on Wednesday, April 30th. Wall Street Zen raised shares of Xylem from a "hold" rating to a "buy" rating in a research report on Saturday, August 9th. Finally, JPMorgan Chase & Co. began coverage on Xylem in a research report on Friday, May 30th. They set an "overweight" rating and a $148.00 price target on the stock. Six research analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus price target of $152.29.

Xylem Profile

Xylem Inc, together with its subsidiaries, engages in the design, manufacture, and servicing of engineered products and solutions worldwide. It operates through four segments: Water Infrastructure, Applied Water, Measurement & Control Solutions, and Integrated Solutions and Services. The Water Infrastructure segment offers products, including water, storm water, and wastewater pumps; controls and systems; filtration, disinfection, and biological treatment equipment; and mobile dewatering equipment and rental services under the ADI, Flygt, Godwin, Sanitaire, Magneto, Neptune Benson, Ionpure, Leopold, Wedeco, and Xylem Vue brands.